Literature DB >> 7959631

Thyroid tumorigenesis.

E D Williams1.   

Abstract

Thyroid tumorigenesis is discussed in the context of the thyroid as a stable tissue, composed of differentiated cells, with a greater dissociation of control of growth from control of differentiation than is found in stem cell tissues. Experimental thyroid carcinogenesis regimes usually use mutagen exposure followed by induced growth. The normal thyroid follicle cell has a limited growth capacity, so loss of one tumour suppressor gene followed by growth-associated loss of heterozygosity would allow escape from this growth limitation, and the formation of a neoplastic clone. In man, there are two pathways of tumour formation, one through follicular adenoma to follicular carcinoma, and one to papillary carcinoma. These two pathways show differing aetiology, and differing oncogene involvement. In the follicular carcinoma pathway TSH-induced growth is relevant as it is in experimental animals. Mutagenesis is important for both papillary and follicular carcinomas. Radiation mutagenesis is of particular current importance because of the occurrence of thyroid carcinoma in children exposed to fallout from Chernobyl. The greater capacity for post-mutagen growth in children than adults is likely to explain the increased radiosensitivity of children, both to external and internal radiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959631     DOI: 10.1159/000184141

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  2 in total

1.  Latency period of thyroid neoplasia after radiation exposure.

Authors:  Shoichi Kikuchi; Nancy D Perrier; Philip Ituarte; Allan E Siperstein; Quan-Yang Duh; Orlo H Clark
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

2.  Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.

Authors:  L Jin; A Burniat; J-E Dumont; F Miot; B Corvilain; B Franc
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.